ATAI Life Sciences(NASDAQ:ATAI) 
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Headquartered in Berlin, with offices
Website: https://www.atai.life/
Founded: 2018
IPO Price: $15 (Jun 18, 2021)
Full Time Employees: 101
Sector: Consumer Defensive
Industry: Education & Training Services
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.30
H 1.35
L 1.25
C 1.31
V 1,549,451
10EMA 1.31
20EMA 1.31
60EMA 1.31
120EMA 1.31
250EMA 1.31